Anti-Cytochrome P450 2A6, 2A7, 2A13 [F16 P2 D8]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (6)
- Inventor Info
Info
![Image for Anti-Cytochrome P450 2A6, 2A7, 2A13 [F16 P2 D8]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,q_auto/4c865666-eb8c-4a62-8447-197202e6ae14.jpg)
![Image for Anti-Cytochrome P450 2A6, 2A7, 2A13 [F16 P2 D8]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,q_auto/d51e39ba-15a8-4771-8fdc-66d369146773.jpg)
![Image for Anti-Cytochrome P450 2A6, 2A7, 2A13 [F16 P2 D8]](https://res.cloudinary.com/ximbio/image/upload/c_limit,fl_lossy,h_282,q_auto,w_368/4c865666-eb8c-4a62-8447-197202e6ae14.jpg)
![Image for Anti-Cytochrome P450 2A6, 2A7, 2A13 [F16 P2 D8]](https://res.cloudinary.com/ximbio/image/upload/c_limit,fl_lossy,h_282,q_auto,w_368/d51e39ba-15a8-4771-8fdc-66d369146773.jpg)
![Image thumbnail for Anti-Cytochrome P450 2A6, 2A7, 2A13 [F16 P2 D8]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/4c865666-eb8c-4a62-8447-197202e6ae14.jpg)
![Image thumbnail for Anti-Cytochrome P450 2A6, 2A7, 2A13 [F16 P2 D8]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/d51e39ba-15a8-4771-8fdc-66d369146773.jpg)
| Catalogue Number | 152164 |
| Applications | ELISA IHC WB |
| Antigen/Gene or Protein Targets | Cytochrome P450 2A6, 2A7and 2A13 (CYP2A6, CYP2A7, CYP2A13) |
| Reactivity | Human |
| Relevance | Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. |
| Host | Mouse |
| Immunogen | ovalbumin-conjugated synthetic peptide RNYTMSFLPR. CYP2A6, CYP2A7and CYP2A13 have the same c-terminal sequence. (C-terminal sequence identical in human and rhesus macaque) |
| Subclass | IgG1 kappa |
| Strain | Balb/c |
| Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References: 6 entries
Murray et al. 2010. Histopathology. 57(2):202-11. PMID: 20716162.
Profiling the expression of cytochrome P450 in breast cancer.
Europe PMC ID: 20716162
Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809.
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
Europe PMC ID: 16243809
Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573.
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
Europe PMC ID: 15897573
Add a reference
References: 6 entries
Murray et al. 2010. Histopathology. 57(2):202-11. PMID: 20716162.
Profiling the expression of cytochrome P450 in breast cancer.
Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809.
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573.
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
Add a reference
